Bioequivalence of a Linagliptin / Metformin Fixed-dose Combination (FDC) Tablet Compared With Single Linagliptin and Metformin Tablets Administered Together in Healthy Volunteers
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Boehringer Ingelheim
Related studies linked through entity extraction aliases.
Relative Bioavailability of Different Formulations of BI 671800 in Healthy Male and Female Volunteers
- Status
- COMPLETED
- Phase
- PHASE1
Safety, Tolerability and Pharmacokinetics of Multiple Rising Doses of Butylated Hydroxytoluene and BI 54903 XX Via Respimat® Soft MistTM Inhaler B in Healthy Male Volunteers
- Status
- COMPLETED
- Phase
- PHASE1
Serial Lung Function Measurements in Healthy and Mild Asthmatic Adults After Oral Inhalation of Ethanolic Solutions Containing Two Concentrations of the Excipient Butylated Hydroxytoluene (BHT) Administered With the Respimat® B (RMT-B)
- Status
- COMPLETED
- Phase
- PHASE1
Safety, Tolerability and Pharmacokinetics of the Fixed Dose Combination of BI 1744 CL Plus BI 54903 XX Via Respimat® B Versus the Free Combination of BI 1744 CL Via Respimat® A and BI 54903 XX Via Respimat® B in Healthy Male and Female Volunteers
- Status
- COMPLETED
- Phase
- PHASE1
Bioequivalence of a 2.5 mg Linagliptin / 850 mg Metformin Fixed Dose Combination Tablet Compared With Single Linagliptin 2.5 mg and Metformin 850 mg Tablets in Healthy Volunteers
- Status
- COMPLETED
- Phase
- PHASE1
Tolerability and Pharmacokinetics of Telmisartan in Combination With Lacidipine in Healthy Male Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Pharmacological Study on Absorption of WE 941 OD Tablets in Japanese Healthy Male Volunteers
- Status
- COMPLETED
- Phase
- PHASE1
Bioequivalence Between WE 941 OD and Brotizolam (Lendormin®) in Healthy Adult Males
- Status
- COMPLETED
- Phase
- PHASE1
Bioequivalence Between WE 941 OD and Brotizolam (Lendormin®) Taken With Water in Healthy Adult Males
- Status
- COMPLETED
- Phase
- PHASE1
Safety, Tolerability and Pharmacokinetics of BI 653048 H3PO4 Oral Drinking Solution in Healthy Male Volunteers
- Status
- COMPLETED
- Phase
- PHASE1
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BI 653048 BS H3PO4 Capsule Multiple Rising Doses in Healthy Male Volunteers
- Status
- COMPLETED
- Phase
- PHASE1
Effects of BI 44370 TA Orally Applied as Tablets on the Pharmacokinetics of Orally Administered Midazolam Solution in Healthy Volunteers
- Status
- COMPLETED
- Phase
- PHASE1
Safety, Tolerability and Pharmacokinetics of BIBW 2948 BS for HandiHaler® in Healthy Male Volunteers
- Status
- COMPLETED
- Phase
- PHASE1
Investigation of Safety, Pharmacokinetics and Pharmacodynamics of Different Doses of BIWH 3 in Patients With Chronic Critical Limb Ischaemia
- Status
- TERMINATED
- Phase
- PHASE1
Post-Marketing Surveillance Study on the Safety and Efficacy of Cymbalta (Duloxetine) on Diabetic Peripheral Neuropathic Pain Among Filipino Patients
- Status
- COMPLETED
- Phase
- N/A
Metabolism and Pharmacokinetics of [14C]-BI 44370 BS Administered as an Oral Solution in Healthy Male Volunteers
- Status
- COMPLETED
- Phase
- PHASE1
Safety, Tolerability and Pharmacokinetics of Multiple Rising Oral Doses of BI 44370 TA Tablets in Healthy Male and Female Volunteers
- Status
- COMPLETED
- Phase
- PHASE1
Bioavailability of BI 44370 TA Drinking Solution or Tablets With and Without a High Fat Meal in Healthy Male and Female Volunteers
- Status
- COMPLETED
- Phase
- PHASE1
The Use of Angiotensin Receptor Blockers and the Risk of Cancer
- Status
- COMPLETED
- Phase
- N/A